These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 7647623)

  • 1. Rural Alberta thrombolysis study. Survey of practice patterns for managing acute myocardial infarction.
    Hindle H; Norheim JK; Renger R
    Can Fam Physician; 1995 Jul; 41():1180-7. PubMed ID: 7647623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombolytic therapy a standard practice.
    Hindle H; Norheim J
    Can Fam Physician; 1993 Aug; 39():1724-5. PubMed ID: 8374355
    [No Abstract]   [Full Text] [Related]  

  • 3. Thrombolytic therapy in acute myocardial infarction: practice pattern at an Arab Middle Eastern centre.
    Zubaid M; Rashed WA
    Acta Cardiol; 2001 Apr; 56(2):115-9. PubMed ID: 11357923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selection factors for the use of thrombolytic treatment in acute myocardial infarction: a population based study of current practice in the United Kingdom. The European Secondary Prevention Study Group.
    Ketley D; Woods KL
    Br Heart J; 1995 Sep; 74(3):224-8. PubMed ID: 7547014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombolysis utilisation in acute myocardial infarction in Bahrain.
    Chawla AK; Nambiar CA; Murad AA
    Indian Heart J; 1996; 48(2):155-8. PubMed ID: 8682556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overutilization and underutilization of thrombolysis in routine clinical practice.
    Sleight P
    J Am Coll Cardiol; 2001 May; 37(6):1588-9. PubMed ID: 11345369
    [No Abstract]   [Full Text] [Related]  

  • 7. New developments in thrombolytic therapy.
    Collen D; Gold HK
    Adv Exp Med Biol; 1990; 281():333-54. PubMed ID: 2129372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A nationwide survey of prescribing patterns for thrombolytic drugs in acute myocardial infarction.
    Grasela TH; Green JA
    Pharmacotherapy; 1990; 10(1):35-41. PubMed ID: 2107535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombolysis after acute myocardial infarction.
    Wald D
    Lancet; 1997 May; 349(9064):1551. PubMed ID: 9167479
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparisons of characteristics and outcomes among women and men with acute myocardial infarction treated with thrombolytic therapy. GUSTO-I investigators.
    Weaver WD; White HD; Wilcox RG; Aylward PE; Morris D; Guerci A; Ohman EM; Barbash GI; Betriu A; Sadowski Z; Topol EJ; Califf RM
    JAMA; 1996 Mar; 275(10):777-82. PubMed ID: 8598594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of economic considerations on clinical decisionmaking: the case of thrombolytic therapy.
    Brody B; Wray N; Bame S; Ashton C; Petersen N; Harward M
    Med Care; 1991 Sep; 29(9):899-910. PubMed ID: 1921539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adoption of thrombolytic therapy in the management of acute myocardial infarction.
    Hlatky MA; Cotugno H; O'Connor C; Mark DB; Pryor DB; Califf RM
    Am J Cardiol; 1988 Mar; 61(8):510-4. PubMed ID: 3125736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Availability of thrombolytic therapy in rural Newfoundland and Labrador.
    Marshall S; Godwin M; Miller R
    CMAJ; 1995 Jan; 152(2):177-81. PubMed ID: 7820799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Guidelines for the use of intravenous thrombolytic agents in acute myocardial infarction. Ontario Medical Association Consensus Group on Thrombolytic Therapy.
    Naylor CD; Armstrong PW
    CMAJ; 1989 Jun; 140(11):1289-99. PubMed ID: 2497946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome of thrombolytic therapy in relation to hospital size and invasive cardiac services. The Investigators of the International Tissue Plasminogen Activator/Streptokinase Mortality Trial.
    Barbash GI; White HD; Modan M; Diaz R; Hampton JR; Heikkila J; Kristinsson A; Moulopoulos S; Paolasso EA; Van der Werf T
    Arch Intern Med; 1994 Oct; 154(19):2237-42. PubMed ID: 7944845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Are ECG criteria for indications for thrombolysis in acute myocardial infarct defined too narrowly?].
    Weiss P; Sarasin C; Ritz R; Pfisterer M
    Schweiz Med Wochenschr; 1991 Dec; 121(49):1829-32. PubMed ID: 1754866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regional variation across the United States in the management of acute myocardial infarction. GUSTO-1 Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries.
    Pilote L; Califf RM; Sapp S; Miller DP; Mark DB; Weaver WD; Gore JM; Armstrong PW; Ohman EM; Topol EJ
    N Engl J Med; 1995 Aug; 333(9):565-72. PubMed ID: 7623907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Thrombolytic treatment in acute myocardial infarction. Choice of preparations in Norwegian hospitals].
    Andreassen AK; Gullestad L; Endresen K
    Tidsskr Nor Laegeforen; 1998 Jun; 118(17):2630-1. PubMed ID: 9673511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of thrombolytic therapy in patients presenting to a peripheral metropolitan emergency department with acute myocardial infarction.
    Jacobs IG; Fatovich DM
    Aust N Z J Med; 1996 Aug; 26(4):539-42. PubMed ID: 8873938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medical decision making in the choice of a thrombolytic agent for acute myocardial infarction. Quebec Acute Coronary Care Working Group.
    Brophy JM; Joseph L; Theroux P
    Med Decis Making; 1999; 19(4):411-8. PubMed ID: 10520679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.